Old Web
English
Sign In
Acemap
>
Paper
>
CXCL17 is a Prognostic Biomarker That Distinguishes Severe Pandemic InfluenzaA(H1N1) from COVID-19
CXCL17 is a Prognostic Biomarker That Distinguishes Severe Pandemic InfluenzaA(H1N1) from COVID-19
2020
José Alberto Choreño Parra
Luis Jiménez Álvarez
Gustavo Ramírez-Martínez
Montserrat Sandoval-Vega
Citlaltepetl Salinas Lara
Carlos Sánchez-Garibay
César Luna-Rivero
Erika Hernández-Montiel
Luis Alejandro Fernández-López
María Fernanda Cabrera-Cornejo
Eduardo M. Choreno-Parra
Alfredo Cruz-Lagunas
Andrea Dominguez
Eduardo Márquez-García
Carlos Cabello Gutiérrez
Francina Valezka Bolanos Morales
Lourdes Mena-Hernández
Diego Delgado-Zaldivar
Daniel Rebolledo-García
Parménides Guadarrama-Ortíz
Nora E. Regino-Zamarripa
Criselda Mendoza-Milla
Ethel García-Latorre
Tatiana Sofía Rodríguez-Reyna
Carmen Hernández-Cárdenas
Shabaana A. Khader
Albert Zlotnik
Joaquín Zúñiga
Keywords:
Coronavirus disease 2019
Internal medicine
Pandemic
prognostic biomarker
Oncology
CXCL17
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]